榮泰健康(603579.SH)擬出資5000萬元參與認購惠每健康基金份額
格隆匯1月13日丨榮泰健康(603579.SH)公佈,近日,公司與惠每頤康(天津)投資管理合夥企業(有限合夥)(以下簡稱“惠每頤康”)簽訂《惠每健康(天津)股權投資基金合夥企業(有限合夥)有限合夥協議》。在確保滿足日常經營資金需求、總體投資風險可控的前提下,為了進一步拓展投資領域,充分利用專業機構的經驗和資源,公司擬作為有限合夥人以自有資金人民幣5000萬元出資認購惠每健康投資總額的2.28%。惠每頤康為股權投資基金的普通合夥人,同時也為股權投資基金的管理人。
合夥企業將通過直接或間接方式對中國境內外非上市醫藥健康與生命科學相關領域優質企業的股權進行投資。合夥企業盈利模式包括通過投資項目退出獲取投資成本與退出收益之間的差額收益,投資項目的分紅、股息、利息,臨時投資收入等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.